a Moderna’s vaccine is the most effective against hospitalization for Covid-19, ahead of the Pfizer vaccine and the single dose of Johnson & Johnson, according to a new study released Friday by the Centers for Disease Control and Prevention (CDC) in the USA.
This new study shows Moderna’s efficacy of 93%, Pfizer/BioNTech’s efficacy of 88% and Janssen’s of 71%.
CDC investigators examined 3,689 adults in 21 hospitals in 18 US states who were hospitalized with severe Covid-19 between March 11 and August 15 this year. The study did not include immunocompromised people.
According to the Centers for Disease Control and Prevention, these new data on differences in efficacy “may guide individual choices and policy recommendations about vaccine boosters,” but any of these three (those authorized by US regulators) offer strong protection.
The study reads that, “Although these data indicate some variability in levels of vaccine protection, all FDA approved or licensed coronavirus vaccines provide significant protection against hospitalization for Covid-19.”
new Tweet embed appears every 3 #covid19 Vaccines used in the United States provide strong protection against hospitalization from COVID-19. The best vaccine is now available to you. # sleeper. more: https://t.co/cSIE2yXeCI pic.twitter.com/kKBFg1rVHx
– CDC (CDCgov) September 17, 2021
Read also: booster dose? Hadith admits that vaccine protection is waning
Always be the first to know.
Consumer Choice for the fifth year in a row for online journalism.
Download our free app.
Andrea Hargraves is a contributor to Brytfmonline.com, covering a broad range of topics including news, politics, business, technology, sports, entertainment, and lifestyle. She is committed to delivering clear, accurate, and reader-focused reporting that helps audiences stay informed about current events and emerging developments. Andrea’s work emphasizes useful information, balanced coverage, and stories that matter to everyday readers, making complex topics accessible and relevant to a wide audience.